Keyphrases
Triple-negative Breast Cancer
100%
Breast Cancer Subtypes
100%
PI3K Pathway
100%
Pathway Alteration
100%
Luminal Androgen Receptor
60%
Receptor Subtypes
30%
Tumor
20%
Basal-like
20%
Pathological Complete Response
20%
PIK3CA mutation
20%
Cancer Agent
10%
Stem Cells
10%
Immunohistochemistry
10%
Statistical Significance
10%
Odds Ratio
10%
Breast Cancer Patients
10%
High Incidence
10%
Breast Tumor
10%
Clinical Trials
10%
Increased Incidence
10%
Whole Exome Sequencing
10%
Pathological Response
10%
RNA Sequencing (RNA-seq)
10%
Line Data
10%
Human Data
10%
Neoadjuvant Therapy
10%
Targeted Agents
10%
Improved Outcomes
10%
Immunomodulatory
10%
PTEN Loss
10%
PTEN mutation
10%
Affect Responses
10%
Evaluation Framework
10%
Immunology and Microbiology
Cell Line
100%
RNA Sequence
100%
Whole Exome Sequencing
100%
Cancer Staging
100%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Androgen Receptor
60%
Neoplasm
30%
Receptor Subtype
30%
Immunohistochemistry
10%
Odds Ratio
10%
Clinical Trial
10%
Cell Line
10%
Cancer Staging
10%
Exome Sequencing
10%
Neoadjuvant Therapy
10%
RNA Sequence
10%
Neuroscience
Androgen Receptor
100%
Receptor Subtype
50%
Immunohistochemistry
16%
Cell Line
16%
Exome Sequencing
16%
RNA Sequence
16%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Clinical Trial
16%
Exome Sequencing
16%
RNA Sequence
16%
Cancer Staging
16%